Castle Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Name: Castle Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Castle Biosciences Inc
Rating: 0.931055625
Author: Trendlyne DVM scores

Weak Stock

about

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes Decision...

18.88 0.00 (0.00%)

57.36% Fall from 52W High

XNAS Volume

XNAS 15 May, 2026 9:29 AM (EDT)

Board Meeting

The next board meeting for Castle Biosciences Inc is on 22 May 2026 for the purpose of Castle Biosciences Inc Annual General Meeting for 2026 See details

Low Financial Strength

5.6 / 100

Mid Valuation

37.3 / 100

Technically Bearish

26.0 / 100

Weak Stock These stocks have weak financials and momentum. Buying interest is low. While the stock is affordable, investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 143%

8 analysts

Castle Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Castle Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes Decision...

57.36% Fall from 52W High

SWOT Analysis

Castle Biosciences Inc Live Price Chart